Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies

Columbia, New York

MSKCC, New York

Fox Chase Cancer Center, Philadelphia

Georgia Cancer Specialists, Atlanta

Mayo Clinic - Jacksonville, Jacksonville

University of Minnesota, Minneapolis

Mayo Clinic, Rochester

University of Chicago, Chicago

MD Anderson Cancer Center, Houston

HonorHealth, Scottsdale

University of Southern California - Norris, Los Angeles

UCLA, Los Angeles

Stanford, Stanford

Oregon Health & Science University, Portland

NCC, Singapore

Dana Farber Cancer Institute, Boston

Alfred University, Melbourne

University Hospital Leuven, Leuven

Cross Cancer Center, Edmonton

Princess Margaret Hospital, Toronto

Helsinki University Central Hospital, Helsinki

Institut Bergonié, Bordeaux

Le Centre Léon Bérard, Lyon

Gustave-Roussy, Villejuif

Sarcoma Center Brandenburg, Brandenburg

University Hospital Essen, Essen

Universitätsmedizin Mannheim, Mannheim

Istituto Nazionale dei Tumori, Milan

Università Campus Bio-Medico di Roma, Rome

Leiden University Medical Center, Leiden

Maria Sklodowska-Curie Memorial Cancer Center, Warsaw

Vall d'Hebron, Barcelona

Hospitalario Universitario Virgen del Rocío, Seville

Royal Marsden, London

University of Sheffield, Sheffield